ThinKeen Strategy Planning & Implementation process stresses the value of a full (and visible) set of strategic alternatives driving profitable growth. In this way we help clients to explore also the less "usual" or less "comfortable" strategic directions and choices, we make sure that not only the organic growth alternatives are evaluated and prioritized but also inorganic and more ambitious pathways are taken in consideration and followed through.
In the Life Science industry, organizations who already enjoy a consolidated international presence are often suffering because of stagnating international sales growth rates while the complexity of international product launches too often delays the long-planned revenue growth. Since new product launches are often unable –alone- to change significantly the international growth rates, heavier cuts of operating expenses often seem necessary to release a stronger international pre-tax growth.
This practice puts the long-term competitive position of the company at risk. Before entering heavily in cost-cutting processes that imply organizational changes and changes of both organizational and individual accountabilities, successful companies take a deeper look at the unexploited top and bottom line potential across markets and products.